• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Covid Update

Full advance of Rs 1,700 crore released to SII for 11 crore Covishield doses on April 28: Govt

The amount, which after TDS was Rs 1699.50 crore, was received by the SII on April 28

  • Press Trust of India
  • Last Updated : May 3, 2021, 15:33 IST
  • Follow
Representative Image
  • Follow

New Delhi: The Health Ministry on Monday said that 100% advance of Rs 1732.50 crore was released to the Serum Institute of India on April 28 for 11 crore doses of Covishield vaccine during May, June and July.

The amount, which after TDS was Rs 1699.50 crore, was received by the SII on April 28 itself, it said.

As on date, against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3, the ministry said, adding, media reports alleging that the Centre has not placed any fresh order for COVID-19 vaccines are “incorrect and not based on facts”.

Additionally, 100% advance of Rs 787.50 crore (after TDS Rs 772.50 crore) was released on April 28 to Bharat Biotech India Ltd (BBIL) for five crore Covaxin doses during May, June and July. The amount was received by them on April 28. As on date against the last order of two crore doses for supplies of Covaxin vaccine, 0.8813 crore doses have been delivered till May 3, the ministry said.

“Hence, to say that fresh orders have not been placed by Government of India is not correct,” it said.

As of May 2, the Centre has provided more 16.54 crore vaccine doses to states and union territories free of cost. More than 78 lakh doses are still available with them to be administered, the ministry said.

“More than 56 lakh doses, in addition, will be received by states and UTs in the next three days,” it stated.

Under the Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy, Government of India would continue to procure its share of 50% of the monthly Central Drugs Laboratory (CDL) cleared vaccines and would continue to make it available to the state governments totally free of cost as was being done earlier, the ministry stated.

Published: May 3, 2021, 15:22 IST

Download Money9 App for the latest updates on Personal Finance.

  • Bharat Biotech
  • covishield
  • covishield vaccine

Related

  • Covid first wave led to increase in antibiotic misuse in India: Study
  • Centre rushes teams to six states reporting a high number of Covid cases
  • Covid-19: India records 46,617 new cases; national recovery rate crosses 97%
  • India’s medical infrastructure well prepared to deal with possible third Covid wave, says FM
  • Karnataka makes RT-PCR negative report, vaccine certificate must for Kerala travellers
  • National Doctors’ Day: Over 1500 doctors sacrificed their lives in fight against Covid-19

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close